European Lab Automation Congress
30 June 2011 - 01 July 2011
The conference, which is the first of its kind to be held in Europe, will offer delegates the chance to sample the latest automation products for life science from over 120 of the world's leading equipment vendors.
Running alongside the exhibition will be 10 distinct conference tracks with over 150 scientific presentations, ranging from compound management in screening to effective tissue and cell biobanking.
Hamburg, Germany
http://www.selectbiosciences.com/conferences/ELA2011/
University of Oxford Nanomedicine Summer School 2011
04 July 2011 - 08 July 2011
This is the third of Oxford University's highly successful nanotechnology Summer Schools. This year it will be focusing on applications of nanotechnology to medicine and healthcare reflecting growing interest in the subject and the University of Oxford's position at the cutting-edge of research and development. The Summer School lasts for five days and the following topics are covered:
Monday 4 July: Introduction to nanomedicine - challenges and opportunities
Tuesday 5 July: Nanotechnologies for regenerative medicine and tissue engineering
Wednesday 6 July: Nano-Diagnostics
Thursday 7 July: Nano-Biosensors
Friday 8 July: Nano-Pharmaceuticals
University of Oxford, UK
http://www.conted.ox.ac.uk/B800-1?utm_source=pgcfreesite&utm_medium=web&utm_campaign=nano2011
3rd WIN Symposium - Personalized Cancer Medicine;
06 July 2011 - 08 July 2011
The WIN Symposium will inaugurate an unprecedented format, where pharma, biotech, academia and patient organizations will be presenting their views on how to address the challenges of efficacy of cancer diagnostics and therapeutics in the era of personalized healthcare, to the benefit of the patients.
Palais des Congrès, Paris, France
http://www.winconsortium.org/symposium.html
6th Assay & Drug Discovery Technologies
07 July 2011 - 08 July 2011
Over the years, the field of assay technologies, laboratory automation, and informatics has taken great leaps in advancement. Present demands from the drug discovery process have propelled a shift in focus from high throughput screening to high content analysis in the assay and drug discovery technology arena. There has also been a push for more physiologically relevant biochemical and cell based assays for compound screening. New avenues for exploration like label-free technology and the use of stem cell screening and nano screening are also emerging on the forefront of discovery techniques. The economic landscape has also created a sense of urgency for the pharmaceutical industry to further reduce the cost of research and development, leading to discussions of the feasibility of outsourcing screening and analysis.
Hyatt at Fisherman's Wharf, San Francisco, CA, USA
http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=6th%20Assay%20&cid=31
Epigenomics, Sequencing & SNiPs-2011
11 July 2011 - 12 July 2011
Mechanisms of Chromatin in gene regulation
Nuclear dynamics and Methylation Assays
Parental imprinting and Histone Deacetylation inhibitors as drugs
Epigenetic re-programming in stem cells
Cutting-edge sequencing technology; Epigenome Sequencing
Epigenetic regulatory processes in diseases & environment
PharmacoEpigenomics
The Joseph B. Martin Conference Center at Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA
http://www.expressgenes.com/Epigenomics2011/main.html